{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:51:33Z","timestamp":1791953493706,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20220818100802005"],"award-info":[{"award-number":["JCYJ20220818100802005"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471010"],"award-info":[{"award-number":["32471010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32561160088"],"award-info":[{"award-number":["32561160088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neuint.2026.106238","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:20:34Z","timestamp":1786429234000},"page":"106238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A new method for the production of recombinant human A\u03b2(1-42) peptide"],"prefix":"10.1016","volume":"200","author":[{"given":"Ping","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzhen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7410-4679","authenticated-orcid":false,"given":"Wei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2026.106238_bib1","article-title":"Identification of the primary peptide contaminant that inhibits fibrillation and toxicity in synthetic amyloid-beta42","volume":"128","author":"Adams","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2026.106238_bib2","article-title":"Homeostatic microglia initially seed and activated microglia later reshape amyloid plaques in Alzheimer's Disease","volume":"151","author":"Baligacs","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2026.106238_bib3","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1038\/s41467-021-25344-6","article-title":"Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia","volume":"121","author":"Bassil","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2026.106238_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic abeta oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"153","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2026.106238_bib5","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/brain\/awz066","article-title":"Identification of neurotoxic cross-linked amyloid-beta dimers in the Alzheimer's brain","volume":"1425","author":"Brinkmalm","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2026.106238_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104956","article-title":"Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies","author":"Casali","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2026.106238_bib7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13287-025-04469-1","article-title":"Pulsed electromagnetic stimulation promotes neuronal maturation by up-regulating cholesterol biosynthesis","volume":"161","author":"Chen","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.neuint.2026.106238_bib8","first-page":"11471","article-title":"An improved method for high-level soluble expression and purification of recombinant amyloid-beta peptide for in vitro studies","author":"Chhetri","year":"2015","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.neuint.2026.106238_bib9","article-title":"Quantification of neurite degeneration with enhanced accuracy and efficiency in an in vitro model of Parkinson's Disease","volume":"92","author":"Clements","year":"2022","journal-title":"eNeuro"},{"key":"10.1016\/j.neuint.2026.106238_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00401-019-02114-9","article-title":"PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins","volume":"1393","author":"Corbett","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2026.106238_bib11","article-title":"Primary microglia isolation from postnatal mouse brains","volume":"168","author":"Du","year":"2021","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuint.2026.106238_bib12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/13506120009146831","article-title":"An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments","volume":"73","author":"Fezoui","year":"2000","journal-title":"Amyloid"},{"key":"10.1016\/j.neuint.2026.106238_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jmb.2009.12.016","article-title":"The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42","volume":"3961","author":"Finder","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuint.2026.106238_bib14","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1002\/cbic.202000125","article-title":"Assessing reproducibility in amyloid beta research: impact of abeta sources on experimental outcomes","volume":"2117","author":"Foley","year":"2020","journal-title":"Chembiochem"},{"key":"10.1016\/j.neuint.2026.106238_bib15","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","article-title":"Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss","volume":"10018","author":"Gong","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2026.106238_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"98","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neuint.2026.106238_bib17","article-title":"An expeditious and facile method of amyloid beta (1-42) purification","volume":"197","author":"Haque","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2026.106238_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuint.2026.106238_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/cn900015v","article-title":"Amyloid \u03b2-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process","volume":"11","author":"Hellstrand","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2026.106238_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13024-025-00872-7","article-title":"A manifesto for Alzheimer's disease drug discovery in the era of disease-modifying therapies","volume":"201","author":"Hering","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2026.106238_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00401-018-1846-7","article-title":"Diffusible, highly bioactive oligomers represent a critical minority of soluble abeta in Alzheimer's disease brain","volume":"1361","author":"Hong","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2026.106238_bib21","article-title":"Methods for the isolation and analysis of abeta from postmortem brain","author":"Hong","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2026.106238_bib24","doi-asserted-by":"crossref","first-page":"18434","DOI":"10.1039\/C8RA00042E","article-title":"Highly efficient soluble expression, purification and characterization of recombinant Abeta42 from Escherichia coli","volume":"833","author":"Jia","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.neuint.2026.106238_bib23","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/acschemneuro.8b00333","article-title":"Amyloidogenicity and cytotoxicity of a recombinant C-Terminal His(6)-Tagged A\u03b2(1-42)","volume":"103","author":"Jia","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2026.106238_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1471-4159.2001.00592.x","article-title":"Vaccination with soluble abeta oligomers generates toxicity-neutralizing antibodies","volume":"793","author":"Lambert","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2026.106238_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-3011.1994.tb00368.x","article-title":"Incomplete fmoc deprotection in solid-phase synthesis of peptides","volume":"431","author":"Larsen","year":"1994","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.neuint.2026.106238_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pep.2004.12.014","article-title":"Production of recombinant amyloid-beta peptide 42 as an ubiquitin extension","volume":"401","author":"Lee","year":"2005","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.neuint.2026.106238_bib28","article-title":"Optimized purification of human amyloid-beta (abeta) 40 and Abeta42 using an E. coli expression system","volume":"58","author":"Lehman","year":"2025","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.neuint.2026.106238_bib29","article-title":"Systematic evaluation of extracellular coating matrix on the differentiation of human-induced pluripotent stem cells to cortical neurons","volume":"261","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2026.106238_bib30","article-title":"Recombinant amyloid beta-peptide production by coexpression with an affibody ligand","volume":"882","author":"Macao","year":"2008","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.neuint.2026.106238_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.stem.2008.08.003","article-title":"A high-efficiency system for the generation and study of human induced pluripotent stem cells","volume":"33","author":"Maherali","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuint.2026.106238_bib32","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jalz.2015.01.005","article-title":"The aqueous phase of Alzheimer's disease brain contains assemblies built from approximately 4 and approximately 7 kDa abeta species","volume":"1111","author":"Mc Donald","year":"2015","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuint.2026.106238_bib33","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer's Disease","volume":"38418","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2026.106238_bib34","article-title":"Microglial phagocytosis induced by fibrillar beta-amyloid is attenuated by oligomeric beta-amyloid: implications for Alzheimer's disease","volume":"645","author":"Pan","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2026.106238_bib35","article-title":"Rapid, refined, and robust method for expression, purification, and characterization of recombinant human amyloid beta 1-42","volume":"22","author":"Prakash","year":"2019","journal-title":"Methods Protoc."},{"key":"10.1016\/j.neuint.2026.106238_bib36","doi-asserted-by":"crossref","first-page":"12451","DOI":"10.1021\/bi701213s","article-title":"Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate","volume":"4643","author":"Rangachari","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2026.106238_bib37","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.2174\/1381612822666160518141911","article-title":"AFM-based single molecule techniques: unraveling the amyloid pathogenic species","volume":"2226","author":"Ruggeri","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuint.2026.106238_bib38","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41591-025-03770-z","article-title":"In Alzheimer's disease, dimers do the damage","volume":"316","author":"Selkoe","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2026.106238_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces abeta plaques in Alzheimer's disease","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2026.106238_bib40","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"148","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2026.106238_bib41","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1021\/acs.biochem.7b00729","article-title":"Aggregation and fibril structure of Abeta(M01-42) and Abeta(1-42)","volume":"5636","author":"Silvers","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2026.106238_bib42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s40478-025-02032-w","article-title":"Experimental evidence that readily diffusible forms of abeta from Alzheimer's disease brain have seeding activity","volume":"131","author":"Song","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuint.2026.106238_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0304-3940(95)12089-M","article-title":"Fibrillogenesis of synthetic amyloid-beta peptides is dependent on their initial secondary structure","volume":"2002","author":"Soto","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2026.106238_bib44","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1021\/acschemneuro.0c00300","article-title":"Fast purification of recombinant monomeric amyloid-beta from E. coli and amyloid-beta-mcherry aggregates from mammalian cells","volume":"1120","author":"Stephens","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2026.106238_bib45","first-page":"67013","article-title":"Preparing synthetic abeta in different aggregation states","author":"Stine","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuint.2026.106238_bib46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1021\/acschemneuro.2c00411","article-title":"Simple, reliable protocol for high-yield solubilization of seedless amyloid-beta monomer","volume":"141","author":"Taylor","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2026.106238_bib47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1873-3468.12526","article-title":"Cross-seeding between Abeta40 and Abeta42 in Alzheimer's disease","volume":"5911","author":"Tran","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuint.2026.106238_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"3881","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2026.106238_bib49","article-title":"Synthetic, cell-derived, brain-derived, and recombinant beta-Amyloid: modelling Alzheimer's disease for research and drug development","volume":"2323","author":"Varshavskaya","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2026.106238_bib50","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1742-4658.2008.06862.x","article-title":"A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide","volume":"2765","author":"Walsh","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.neuint.2026.106238_bib51","doi-asserted-by":"crossref","first-page":"11947","DOI":"10.1523\/JNEUROSCI.2009-17.2017","article-title":"Human brain-derived abeta oligomers bind to synapses and disrupt synaptic activity in a manner that requires APP","volume":"3749","author":"Wang","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2026.106238_bib52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00401-013-1083-z","article-title":"Oligomers, fact or artefact? SDS-PAGE induces dimerization of beta-amyloid in human brain samples","volume":"1254","author":"Watt","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2026.106238_bib53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13195-015-0100-y","article-title":"A highly sensitive novel immunoassay specifically detects low levels of soluble abeta oligomers in human cerebrospinal fluid","volume":"71","author":"Yang","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuint.2026.106238_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/psc.801","article-title":"Synthesis of Abeta[1-42] and its derivatives with improved efficiency","volume":"132","author":"Zarandi","year":"2007","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.neuint.2026.106238_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pep.2008.10.007","article-title":"Expression, purification, and characterization of recombinant human beta-amyloid42 peptide in Escherichia coli","volume":"641","author":"Zhang","year":"2009","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.neuint.2026.106238_bib56","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","article-title":"Rapid single-step induction of functional neurons from human pluripotent stem cells","volume":"785","author":"Zhang","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2026.106238_bib57","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1126\/science.aay0198","article-title":"A vicious cycle of beta amyloid-dependent neuronal hyperactivation","author":"Zott","year":"2019","journal-title":"Science"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018626001294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018626001294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:41:46Z","timestamp":1791952906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018626001294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":57,"alternative-id":["S0197018626001294"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2026.106238","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new method for the production of recombinant human A\u03b2(1-42) peptide","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2026.106238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106238"}}